Metabolic Syndrome, Cardiovascular Disease, and the Hair Growth Cycle: Addressing Hair Growth Disruptions Using Nourkrin with Marilex as a Proteoglycan Replacement Therapy: A Concise Review
May 2018
Studysummary This review discusses the association between alopecia and increased cardiovascular and metabolic risk but reports no definitive clinical results, emphasizing the need for more comprehensive studies on androgenetic alopecia patients.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on heighpubs.org →